Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines

A non-steroidal anti-inflammatory drug, multi-layer tablet technology, applied in the direction of anti-inflammatory agents, drug combinations, medical preparations containing active ingredients, etc., can solve the problem of decongestants and antihistamines that cannot alleviate the side effects of decongestants and antihistamines in sensitive individuals , can not provide a wide range of sleepless effects and other problems
CN101065112AInactive Publication Date: 2007-10-31WYETH LLC
2 Cites 5 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
WYETH LLC
Publication Date
2007-10-31
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
Patent Text Reader

Abstract

The present invention is directed to a pharmaceutical composition and method for treatment of rhinitis and cold like symptoms, the composition includes a non-steroidal anti-inflammatory drug (NSAID), a decongestant and an antihistamine preferably in a multi-layer tablet comprising an immediate release layer and an extended release layer to optimize the delivery profile and match the duration of biological action of the multiple active agents.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Cross References to Related Applications

[0002]

[001] This application claims priority to U.S. Application 10 / 859,256, filed June 2, 2004, entitled "Compositions of Non-Steroidal Anti-Inflammatory Drugs, Decongestants, and Antihistamines," which is hereby incorporated The entire content is for reference only.

[0003]

[002] This application also claims priority to U.S. Patent Application 10 / 740,386, a continuation-in-part, filed on December 17, 2003, which claims the benefit of U.S. Provisional Application 60 / 434,342, filed on December 18, 2002, at Both are incorporated herein by reference. technical field

[0004]

[003] The present invention relates to improved dosage forms of medicines for the treatment of allergy and cold-related rhinitis. Background technique

[0005] Decongestants and antihistamines

[0006]

[004] Rhinitis refers to an inflammatory disorder of the nasal passages. Symptoms of rhinitis usually include sneezing, runny nose, nasal congestion, a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More